Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study

NCT02147106 | Completed

• 1 other identifier: VIDEO-NET-2014
• Study Type: observational
• Target: 26
• Locations: 1 country
• Sites: 1

Brief Summary

Rationale: Patients with neuroendocrine tumors (NET) have a rare disease. Due to treating patients with a neuroendocrine tumor in 'NET knowledge centers' patients often have to travel long distances for follow-up visits at the outpatient clinic. Patients whose medical condition allows videoconsultation could save time by replacing outpatient clinic visits through videoconsultation for receiving follow-up care. Therefore, in this study we aim to introduce videoconsultation as a alternative for follow-up outpatient clinic visits in NET patients. Objective: The primary objective is to assess if use of videoconsultation in follow-up care for NET patients is feasible. We hypothesize that videoconsultation is a suitable medium for providing follow-up care in NET patients. Secondary objectives are to explore the amount of time videoconsultation takes in comparison with outpatient clinic visits and the acceptability and satisfaction of physicians and patients with using videoconsultation in follow-up care. Study design: The present study is a single-centre prospective feasibility study. Study population: Adult NET patients under surveillance or treatment of the department Medical Oncology at the University Medical Centre Groningen (UMCG) whose medical condition allows videoconsultation will be invited to participate. Intervention: Patient who give informed consent will participate in the study. Participants will receive follow-up care through videoconsultation instead of conventional visits at the outpatient clinic. Main study parameters/endpoints: The main endpoint is the feasibility of videoconsultation for follow-up care in NET patients. We hypothesize that videoconsultation is a suitable medium for providing follow-up care.

Conditions

Neuroendocrine Tumor

Keywords

Neuroendocrine tumor; Videoconsultation; Feasibility

Outcome Measures

Primary Outcomes (1)

• Feasibility

  Participation rates, reason for declining participation, number of completed videoconsultations, dropout rate and reason for dropout will be noted in study records to evaluate feasibility of videoconsultation

  1 year

Secondary Outcomes (3)

• Amount of time

  1 year

• Acceptability and satisfaction of patients

  1 year

• Acceptability and satisfaction of physicians

  1 year

Study Arms (1)

Videoconsultation

Performing two videoconsulations with the treating medical oncologist

Other: Videoconsultation

Interventions

Videoconsultation OTHER

Videoconsultation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Neuroendocrine tumor patients (grade 1 and 2) whose medical condition allows videoconsultation.

You may qualify if:

• Signed informed consent
• Age ≥ 18 yrs
• Grade I or II (low and intermediate grade) NET with any primary tumor type or disease stage
• Have access to required equipment/technology for performing videoconsultation

You may not qualify if:

• Newly referred NET patients, who are visiting the department of Medical Oncology at the UMCG for the first time
• Recently diagnosed NET patients, who are in the diagnostic phase of the disease
• NET patients who frequently require blood tests, consultation or physical examination
• A hearing or visual impairment, which would make videoconsultation difficult

Sponsors & Collaborators

• University Medical Center Groningen: lead

Study Sites (1)

University Medical Center Groningen

Groningen, 9713 GZ, Netherlands

Location

MeSH Terms

Conditions

Neuroendocrine Tumors

Condition Hierarchy (Ancestors)

Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms; Neoplasms, Nerve Tissue

Study Officials

• A.M.E. Walenkamp, MD PhD

  University Medical Center Groningen

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 19, 2014
• First Posted: May 26, 2014
• Study Start: May 1, 2014
• Primary Completion: March 1, 2017
• Study Completion: March 1, 2017
• Last Updated: May 6, 2024

Record last verified: 2024-05

Locations

NL (1)